Avidity Biosciences (Series B)

Funding Details
Awarder
Inbox
Date Award
January 05, 2017
Vertical
Biotechnology
Funding URL
View Funding Page
Funding Amount:
$16,000,000

Company Info
Traction
Avidity has entered research collaborations with leading biopharma companies and is actively seeking additional partnerships.
Founders
Troy Wilson, Ph.D., J.D.
Company Description
Avidity Biosciences is a biotechnology company that develops oligonucleotide-based therapies for its patients.
Market
Precision medicines
Location
La Jolla, California, USA
Coinvestors
Alethea Capital Management, Alexandria Real Estate Equities, Brace Pharma, EcoR1 Capital, F-Prime Capital Partners, Moore Venture Partners, Takeda Pharmaceutical Company, Tavistock Life Sciences

Links